Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 2, 2004, Pages 327-336

  Capitosti, Scott M ^a   Hansen, Todd P ^a   Brown, Milton L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Endothelial cells; Phthalimide; Prostate cancer; Structure activity relationships

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; THALIDOMIDE DERIVATIVE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROVASCULATURE; PROSTATE CARCINOMA;

EID: 0347320710     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.11.007     Document Type: Article

References (43)

1. Li J., Zhang Y.-P., Kirsner R. Micros. Res. Tech. 60:2003;107.
2. Reynolds L.P., Grazul-Bilska A.T., Redmer D.A. Int. J. Exp. Pathol. 83:2002;151.
3. Matter A. Drug Discovery Today. 6:2001;1005.
4. Bodolay E., Koch A.E., Kim J., Szegedi Z. J. Cell. & Mol. Med. 6:2002;357.
5. Noma H., Funatsu H., Yamashita H., Kitano S., Mishima H.K., Hori S. Arch. Ophthalmol. 120:2002;1075.
6. Fantl W.J., Rosenberg S. Anti-angiogenesis as a Therapeutic Strategy for Cancer. Doherty A.M. Annual Reports in Medicinal Chemistry. 2000;123 Academic, San Diego, CA.
7. Eriksson T., Björkman S., Höglund P. Eur. J. Clin. Pharmacol. 57:2001;365.
8. Arora M., Wagner J.E., Davies S.M., Blazar B.R., Defor T., Enright H., Miller W.J., Weisdorf D.F. Biol. Blood Marrow Transplant. 7:2001;265.
9. Gaziev D., Lucarelli G. Exp. Opin. Invest. Drugs. 10:2001;909.
10. Teo S.K., Resztak K.E., Scheffler M.A., Kook K.A., Zeldis J.B., Stirling D.I., Thomas S.D. Microbes Infection. 4:2002;1193.
11. Sheskin J. Clin. Pharmacol. Ther. 6:1965;303.
12. Grosshans E., Illy G. Int. J. Dermatol. 23:1984;598.
13. Kruse F.E., Joussen A.M., Rohrschneider K., Becker M.D., Volcker H.E. Graefes Archive for Clini. Exp. Ophthalmol. 236:1998;6. 461.
14. D'Amato R.J., Loughnan M.S., Flynn E., Folkman J. Natil. Acad. Sci. U.S.A. 91:1994;4082.
15. Kenyon B.M., Browne F., D'Amato R.J. Exp. Eye Res. 64:1997;971.
16. Chu K.C., Tarone R.E., Freeman H.P. Cancer. 97:2003;1507.
17. Harris R., Lohr K.N. Ann. Int. Med. 137:2002;917.
18. van Moorselaar R.J.A., Voest E.E. Mol. Cell. Endocrinol. 197:2002;239.
19. Frydenberg M., Stricker P.D., Kaye K.W. Lancet. 349:1997;1681.
20. Figg W.D., Dahut W., Duray P., Hamilton M., Tompkins A., Steinberg S.M., Jones E., Premkumar A., Linehan W.M., Floeter M.K., Chen C.C., Dixon S., Kohler D.R., Krüger E.A., Gubish E., Pluda J.M., Reed E. Clin. Cancer Res. 7:2001;1888.
21. Ng S.S.W., Gütschow M., Weiss M., Hauschildt S., Teubert U., Hecker T.K., Luzzio F.A., Kruger E.A., Eger K., Figg W.D. Cancer. 63:2003;3189.
22. Shah J.H., Swartz G.M., Papathanassiu A.E., Treston A.M., Fogler W.E., Madsen J.W., Green S.J. J. Med. Chem. 42:1999;3014.
23. Miyachi H., Azuma A., Ogasawara A., Uchimura E., Watanabe N., Kobayashi Y., Kato F., Kato M., Hashimoto Y. J. Med. Chem. 40:1997;2858.
24. Miyachi H., Azuma A., Kitamoto T., Hayashi K., Kato S., Koga M., Sato B., Hashimoto Y. Bioorg. Med. Chem. Lett. 7:1997;1483.
25. Niwayama S., Turk B.E., Liu J.O. Journal of Medicinal Chemistry. 39:1996;3044.
26. Niwayama S., Loh C., Turk B.E., Liu J.O., Miyachi H., Hashimoto Y. Bioorg. and Med. Chem. Lett. 8:1998;1071.
27. Shibata Y., Sasaki K., Hashimoto Y. Biochem. Biophys. Res. Comm. 205:1994;1992.
28. Hartmann K.-H., Troll T. Tetrahedron. 51:1995;4655.
29. Ballini R., Barboni L., Filippone P. Chemistry Letters. 5:1997;475.
30. Bauer K.S., Dixon S.C., Figg W.D. Biochem. Pharmacol. 55:1998;1827.
31. Filler R., Kobayashi Y., Yagupolskii L.M. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications. 1993;Elsevier, Amsterdam.
32. Gordon G.B., Spielberg S.P., Blake D.A., Balasubramanian V. Natl. Acad. Sci. U.S.A. 78:1981;2545.
33. Perry C.J., Parveen Z. J. Chem. Soc. Perkin Trans. 2. 2001;512.
34. Michman M., Patai S., Wiesel Y. J. Chem. Soc.: Perkin Trans. 1. 1977;1705.
35. Kjeldgaard K. Arzneimittel-Forschung. 12:1962;1207.
36. López-Alvarado P., Avendaño C., Menéndez J.C. J. Org. Chem. 61:1996;5865.
37. Rosenthal A., Weir M.R.S. J. Org. Chem. 28:1963;3025.
38. Reynolds R.D., Anderson G.L. J. Org. Chem. 28:1963;3223.
39. Bacon R.G.R., Karim A. J. Chem. Soc. Perkin Trans. 1. 1973;272.
40. Shibata Y., Sasaki K., Hashimoto Y., Iwasaki S. Chem. Pharm. Bull. 44:1996;156.
41. Ghislandi V., La Manna A. Farmaco Ed. Sci. 31:1976;489.
42. Khanna J.M., Chak I.M., Anand N. Indian J. Chem. 5:1967;347.
43. Vejdelek Z.J., Protiva M. Coll. Czech. Chem. Commun. 36:1971;1611.